ESR1 and breast cancer: Based on the estrogen receptor (ER) and ERBB2/HER2 receptor four molecularly distinct BC subtypes can be distinguished [2] i.e., luminal A/ER+, luminal B/ER+, ERBB2/HER2+, and basal/triple-negative [3].